Trials / Completed
CompletedNCT03543982
Effects of Oral Probiotic Product on Vaginal Microbial Community and Parameters of Vaginal Health
An Open-label, Pilot Study to Assess the Effects of an Oral Probiotic Product on the Vaginal Microbial Community and on Parameters of Vaginal Health
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 37 (actual)
- Sponsor
- UAS Labs LLC · Industry
- Sex
- Female
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of the study is to assess the efficacy and safety of an oral probiotic product on the vaginal microbiome and on parameters of vaginal health. Eligible subjects will utilize the investigational product as directed for a period of 28 days. The vaginal microbial community and parameters of vaginal health will be measured at baseline and after 14 and 28 days of supplementation. A follow-up post-supplementation visit will be conducted on Day 42.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Oral probiotic product | Once per day (QD), 28 days |
Timeline
- Start date
- 2018-05-23
- Primary completion
- 2020-10-01
- Completion
- 2021-03-18
- First posted
- 2018-06-01
- Last updated
- 2021-04-08
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT03543982. Inclusion in this directory is not an endorsement.